NM_032383.5:c.2215G>A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_032383.5(HPS3):​c.2215G>A​(p.Gly739Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0145 in 1,613,918 control chromosomes in the GnomAD database, including 223 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 15 hom., cov: 33)
Exomes 𝑓: 0.015 ( 208 hom. )

Consequence

HPS3
NM_032383.5 missense

Scores

5
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 5.81
Variant links:
Genes affected
HPS3 (HGNC:15597): (HPS3 biogenesis of lysosomal organelles complex 2 subunit 1) This gene encodes a protein containing a potential clathrin-binding motif, consensus dileucine signals, and tyrosine-based sorting signals for targeting to vesicles of lysosomal lineage. The encoded protein may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 3. [provided by RefSeq, Apr 2015]
CP (HGNC:2295): (ceruloplasmin) The protein encoded by this gene is a metalloprotein that binds most of the copper in plasma and is involved in the peroxidation of Fe(II)transferrin to Fe(III) transferrin. Mutations in this gene cause aceruloplasminemia, which results in iron accumulation and tissue damage, and is associated with diabetes and neurologic abnormalities. Two transcript variants, one protein-coding and the other not protein-coding, have been found for this gene. [provided by RefSeq, Feb 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009357303).
BP6
Variant 3-149162256-G-A is Benign according to our data. Variant chr3-149162256-G-A is described in ClinVar as [Benign]. Clinvar id is 226654.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0101 (1545/152270) while in subpopulation NFE AF= 0.0167 (1135/68030). AF 95% confidence interval is 0.0159. There are 15 homozygotes in gnomad4. There are 707 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 15 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HPS3NM_032383.5 linkc.2215G>A p.Gly739Arg missense_variant Exon 12 of 17 ENST00000296051.7 NP_115759.2 Q969F9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HPS3ENST00000296051.7 linkc.2215G>A p.Gly739Arg missense_variant Exon 12 of 17 1 NM_032383.5 ENSP00000296051.2 Q969F9-1

Frequencies

GnomAD3 genomes
AF:
0.0102
AC:
1545
AN:
152152
Hom.:
15
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00282
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00845
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0124
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0167
Gnomad OTH
AF:
0.00958
GnomAD3 exomes
AF:
0.00967
AC:
2428
AN:
251124
Hom.:
24
AF XY:
0.00903
AC XY:
1226
AN XY:
135700
show subpopulations
Gnomad AFR exome
AF:
0.00308
Gnomad AMR exome
AF:
0.00655
Gnomad ASJ exome
AF:
0.00318
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00111
Gnomad FIN exome
AF:
0.0125
Gnomad NFE exome
AF:
0.0154
Gnomad OTH exome
AF:
0.0113
GnomAD4 exome
AF:
0.0149
AC:
21822
AN:
1461648
Hom.:
208
Cov.:
32
AF XY:
0.0145
AC XY:
10568
AN XY:
727144
show subpopulations
Gnomad4 AFR exome
AF:
0.00230
Gnomad4 AMR exome
AF:
0.00683
Gnomad4 ASJ exome
AF:
0.00310
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00115
Gnomad4 FIN exome
AF:
0.0129
Gnomad4 NFE exome
AF:
0.0178
Gnomad4 OTH exome
AF:
0.0126
GnomAD4 genome
AF:
0.0101
AC:
1545
AN:
152270
Hom.:
15
Cov.:
33
AF XY:
0.00950
AC XY:
707
AN XY:
74436
show subpopulations
Gnomad4 AFR
AF:
0.00282
Gnomad4 AMR
AF:
0.00843
Gnomad4 ASJ
AF:
0.00346
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0124
Gnomad4 NFE
AF:
0.0167
Gnomad4 OTH
AF:
0.00948
Alfa
AF:
0.0136
Hom.:
28
Bravo
AF:
0.00949
TwinsUK
AF:
0.0178
AC:
66
ALSPAC
AF:
0.0192
AC:
74
ESP6500AA
AF:
0.00454
AC:
20
ESP6500EA
AF:
0.0157
AC:
135
ExAC
AF:
0.00955
AC:
1159
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0142
EpiControl
AF:
0.0136

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Gly739Arg in exon 12 of HPS3: This variant is not expected to have clinical sign ificance because it has been identified in 1.6% (135/8600) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs78336249). -

Hermansky-Pudlak syndrome 3 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Hermansky-Pudlak syndrome Benign:1
Nov 11, 2019
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.37
T;T
Eigen
Benign
0.13
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.80
T;T
MetaRNN
Benign
0.0094
T;T
MetaSVM
Benign
-0.73
T
MutationAssessor
Benign
0.95
L;.
PrimateAI
Benign
0.48
T
PROVEAN
Uncertain
-2.5
N;D
REVEL
Benign
0.25
Sift
Benign
0.035
D;T
Sift4G
Uncertain
0.0050
D;D
Polyphen
0.32
B;P
Vest4
0.37
MutPred
0.65
Gain of solvent accessibility (P = 0.019);.;
MVP
0.85
MPC
0.15
ClinPred
0.018
T
GERP RS
5.1
Varity_R
0.24
gMVP
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs78336249; hg19: chr3-148880043; API